Free Trial

Syros Pharmaceuticals (SYRS) Earnings Date, Estimates & Call Transcripts

Syros Pharmaceuticals logo
$2.52
+0.01 (+0.40%)
(As of 10/31/2024 ET)

Earnings Summary

Latest
Earnings Date
Oct. 31Confirmed
Actual EPS
(Oct. 31)
-$0.16 Beat By $0.51
Consensus EPS
(Oct. 31)
-$0.67
Skip Charts & View Estimated and Actual Earnings Data

SYRS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SYRS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Syros Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($1.20)($0.74)($0.98)
Q2 20243($1.00)($0.73)($0.83)
Q3 20243($0.74)($0.50)($0.65)
Q4 20243($0.75)($0.53)($0.66)
FY 202412($3.69)($2.50)($3.12)

SYRS Earnings Date and Information

Syros Pharmaceuticals last posted its quarterly earnings data on October 31st, 2024. The reported $0.00 EPS for the quarter, beating analysts' consensus estimates of ($0.67) by $0.67. Syros Pharmaceuticals has generated ($5.01) earnings per share over the last year (($5.01) diluted earnings per share). Earnings for Syros Pharmaceuticals are expected to decrease in the coming year, from ($2.88) to ($2.96) per share. Syros Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, October 31st, 2024.

Syros Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
10/31/2024Q3 2024($0.67)($0.16)+$0.51---  
7/31/2024Q2 2024($0.79)($0.70)+$0.09($0.81)--
5/14/2024Q1 2024($0.89)($0.79)+$0.10($1.48)$1.30 million-      
3/27/2024Q4 2023($1.23)($1.19)+$0.04($0.20)$2.40 million$0.39 million
11/14/2023Q3 2023($1.12)($1.35)($0.23)($1.27)$3.90 million$3.76 million  
8/8/2023Q2 2023($1.11)($1.30)($0.19)($1.30)$3.17 million$2.83 million  
5/10/2023Q1 2023($1.12)($0.85)+$0.27($0.85)$2.95 million$2.95 million  
3/2/2023Q4 2022($1.27)($1.28)($0.01)($2.39)$3.28 million($0.75) million      
11/14/2022Q3 2022($3.91)($2.41)+$1.50($1.61)$4.97 million$3.89 million  
8/9/2022Q2 2022($4.20)($5.40)($1.20)($0.54)$4.68 million$6.28 million  
5/16/2022Q1 2022($4.80)($4.00)+$0.80($0.40)$4.56 million$5.47 million      
3/15/2022Q4 2021($4.40)($4.20)+$0.20($0.46)$5.65 million$7.80 million    
11/5/2021Q3 2021($4.40)($4.10)+$0.30($0.41)$5.10 million$5.70 million  
8/5/2021Q2 2021($3.60)($3.60)-($0.36)$4.58 million$5.16 million    
5/6/2021Q1 2021($5.50)($2.30)+$3.20($0.23)$3.05 million$4.83 million  
3/4/2021Q4 2020($5.40)($6.20)($0.80)($0.60)$3.20 million$5.70 million  
11/5/2020Q3 2020($3.80)($4.30)($0.50)($0.43)$2.83 million$3.83 million  
8/6/2020Q2($4.00)($3.80)+$0.20($0.38)$2.19 million$3.19 million  
5/7/2020Q1 2020($4.50)($3.90)+$0.60($0.39)$1.72 million$2.38 million  
3/5/2020Q4 2019($4.70)($4.60)+$0.10($0.46)$0.79 million$0.51 million  
11/12/2019Q3($4.80)($4.70)+$0.10($0.47)$0.43 million$0.56 million  

Syros Pharmaceuticals Earnings - Frequently Asked Questions

When is Syros Pharmaceuticals's earnings date?

Syros Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, October 31st, 2024. Learn more on SYRS's earnings history.

Did Syros Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Syros Pharmaceuticals (NASDAQ:SYRS) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.67) by $0.67. Learn more on analysts' earnings estimate vs. SYRS's actual earnings.

How can I listen to Syros Pharmaceuticals's earnings conference call?

The conference call for Syros Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Syros Pharmaceuticals generate each year?

Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded annual revenue of $4.15 million.

How much profit does Syros Pharmaceuticals generate each year?

Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded net income of -$164.57 million. SYRS has generated -$5.01 earnings per share over the last four quarters.

What is Syros Pharmaceuticals's EPS forecast for next year?

Syros Pharmaceuticals's earnings are expected to decrease from ($2.88) per share to ($2.96) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:SYRS) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners